Mucus, often overlooked, plays a crucial role in our bodies as a first line of defense against pathogens, a habitat for microbiomes, and a lubricant for our internal systems. Understanding how mucus changes in response to infections or diseases is key to developing effective treatments. However, designing experiments to study the physical properties of mucus has been a challenge.

Now, researchers from Stanford University have developed a novel platform to grow mucus-producing intestinal cells and study the characteristics of the mucus under different conditions, such as exposure to pathogens or potential medications. Their approach, described in APL Bioengineering, overcomes the limitations of traditional animal studies, which are expensive, complex, and unpleasant for the animals.

Search Antibodies
Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.

Conventionally, researchers would surgically remove intestinal mucus from lab animals after inducing an infection or administering a drug. However, this process likely alters the mucus properties, rendering the results unreliable. The Stanford team's alternative involves growing a layer of intestinal cells on a laboratory plate exposed to air, allowing the cells to produce a mucus layer that can be easily accessed for testing. 

Using a magnetic wire, the researchers can measure the consistency of the mucus without affecting its properties. "We put this wire on the mucus layer of the live cells, and then we applied a magnetic force to this probe and measured its displacement," explained co-author Margaret Braunreuther. "From the relationship between the applied force and the magnetic wire displacement, we can then calculate the rheological properties of the material."

To demonstrate their platform's capabilities, the team simulated a parasitic worm infection and observed how the mucus responded, providing insights into potential treatments. The group is now exploring applications for studying airway mucus in conditions like cystic fibrosis and acute asthma, as well as collaborating to develop drugs that can restore a healthy mucus response.

This novel approach allows researchers to study mucus in its natural state, paving the way for a better understanding of mucus-related diseases and the development of targeted therapies.